Keywords: ریفلاکس; Mantle cell lymphoma; Ibrutinib; Novel therapies; Bruton's tyrosine kinase inhibitors; Bortezomib; Lenalidomide; Relapsed; Refractory; Ibrutinib combinations;
مقالات ISI ریفلاکس (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ریفلاکس; Multiple myeloma; Relapsed; Refractory; Elderly; Cytogenetics;
Keywords: ریفلاکس; Multiple myeloma; Relapsed; Autologous stem cell transplant; Melphalan
Keywords: ریفلاکس; Bendamustine; Brentuximab vedotin; Hodgkin's lymphoma; Refractory; Relapsed
Keywords: ریفلاکس; Pomalidomide; Relapsed; Refractory; Multiple myeloma; Immunomodulatory; IMiD
Keywords: ریفلاکس; Carfilzomib; Proteasome inhibitor; Relapsed; Refractory; Newly-diagnosed; Multiple myeloma; Dosing; Schedule;
Mycophenolate Mofetil for the Treatment of Subcutaneous Panniculitis-Like T-Cell Lymphoma: Case Report and Review of the Literature
Keywords: ریفلاکس; Cutaneous T-cell lymphoma; Immunosuppression; Relapsed; Steroid-sparing; αβ T-cell;
Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)
Keywords: ریفلاکس; Acute myeloid leukemia; Relapsed; Refractory; Pravastatin; Idarubicin; Cytarabine;
Heterogeneity of Second-Line Treatment for Patients With Multiple Myeloma in the Connect MM Registry (2010-2016)
Keywords: ریفلاکس; Community; Real-world; Refractory; Relapsed; Therapies;
Research paperEfficacy and safety of G-CSF, low-dose cytarabine and aclarubicin in combination with l-asparaginase, prednisone in the treatment of refractory or relapsed acute lymphoblastic leukemia
Keywords: ریفلاکس; Acute lymphoblastic leukemia; Primary refractory; Relapsed; Salvage treatment;
Triplet versus doublet combination regimens for the treatment of relapsed or refractory multiple myeloma: A meta-analysis of phase III randomized controlled trials
Keywords: ریفلاکس; Multiple myeloma; Relapsed; Refractory; Triplets; Efficacy; Meta-analysis;
Peripheral T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease
Keywords: ریفلاکس; Alisertib; ARGX-110; Belinostat; Bendamustine; Brentuximab vedotin; Copanlisib; Duvelisib; Gemcitabine; Lenalidomide; Mogamulizumab; Peripheral T-cell lymphoma; Pralatrexate; Refractory; Relapsed; Romidepsin; Selinexor;
Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational, Retrospective, Cohort Study
Keywords: ریفلاکس; Anti-MM treatment; Cardiotoxicity; Database analysis; Refractory; Relapsed;
Phase II Study of Bendamustine in Relapsed Chemotherapy Sensitive or Resistant Small-Cell Lung Cancer
Keywords: ریفلاکس; Bendamustine; Small-cell lung cancer; Relapsed; Refractory; Phase II
Docetaxel and Carboplatin as Salvage Therapy for First-Relapsed, Platinum-Sensitive, Stage III/IV Advanced Ovarian Cancer
Keywords: ریفلاکس; Ovary cancer; Relapsed; Salvage therapy
ReviewClinical Efficacy and Safety in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Systematic Literature Review
Keywords: ریفلاکس; Chemotherapy; Diffuse large B-cell lymphoma; Refractory; Relapsed;
Meta-Analysis of the Efficacy and Safety of Bortezomib Re-Treatment in Patients With Multiple Myeloma
Keywords: ریفلاکس; Meta-regression analysis; Overall response rate; Random-effect model; Refractory; Relapsed;
Etoposide in combination with low-dose CAG (cytarabine, aclarubicin, G-CSF) for the treatment of relapsed or refractory acute myeloid leukemia: A multicenter, randomized control trial in southwest China
Keywords: ریفلاکس; Acute myeloid leukemia; Refractory; Relapsed; Etoposide; Recombinant human granulocyte colony-stimulating factor; Aclarubicin; Hematopoietic stem cell transplantation;
Tumor associated macrophages in relapsed and refractory Hodgkin lymphoma
Keywords: ریفلاکس; Hodgkin lymphoma; Relapsed; Refractory; CD68
A phase I study of decitabine and rapamycin in relapsed/refractory AML
Keywords: ریفلاکس; AML; Decitabine; Rapamycin; Phase I; Relapsed; Refractory
Factors affecting survival in patients aged 60 and over with diffuse large B cell lymphoma failing first-line therapy
Keywords: ریفلاکس; Aggressive; Lymphoma; Elderly; Relapsed; Refractory
Irinotecán y temozolomida en tumores sólidos pediátricos en recaída o refractarios
Keywords: ریفلاکس; Irinotecán; Temozolomida; Tumores sólidos; Recaída; RefractariosIrinotecan; Temozolomide; Solid tumors; Relapsed; Refractory
Impact of Pretransplantation Conditioning Regimens on Outcomes of Allogeneic Transplantation for Chemotherapy-Unresponsive Diffuse Large B Cell Lymphoma and Grade III Follicular Lymphoma
Keywords: ریفلاکس; DLBCL; Grade III follicular lymphoma; Allogeneic transplantation; Refractory; Relapsed; Graft-versus-host disease
Pralatrexate Is an Effective Treatment for Relapsed or Refractory Transformed Mycosis Fungoides: A Subgroup Efficacy Analysis From the PROPEL Study
Keywords: ریفلاکس; Antifolate; Efficacy; Relapsed; Refractory peripheral T-cell lymphoma; Safety; Transformed mycosis fungoides
Outcomes of surgical management of bowel obstruction in relapsed epithelial ovarian cancer (EOC)
Keywords: ریفلاکس; Bowel obstruction; Relapsed; Ovarian cancer
Efficacy and Toxicity of Belotecan for Relapsed or Refractory Small Cell Lung Cancer Patients
Keywords: ریفلاکس; Belotecan; Relapsed; Refractory; Small cell lung cancer
Salvage chemotherapy regimens for acute myeloid leukemia: Is one better? Efficacy comparison between CLAG and MEC regimens
Keywords: ریفلاکس; Acute myeloid leukemia; Relapsed; Refractory; CLAG regimen; MEC regimen
Long-Term Survival After Treatment with Gemcitabine and Oxaliplatin With and Without Paclitaxel Plus Secondary Surgery in Patients with Cisplatin-Refractory and/or Multiply Relapsed Germ Cell Tumors
Keywords: ریفلاکس; Germ cell tumor; Cisplatin-refractory; Relapsed; Gemcitabine; Oxaliplatin; Paclitaxel; Residual tumor resection
Second-line chemotherapy for small-Cell Lung Cancer (SCLC)
Keywords: ریفلاکس; Small-cell lung cancer; Relapsed; Chemotherapy; Second-line; Sensitive; Refractory
Response to Second-line Therapy Defines the Potential for Cure in Patients With Recurrent Diffuse Large B-Cell Lymphoma: Implications for the Development of Novel Therapeutic Strategies
Keywords: ریفلاکس; Outcome assessment; Refractory; Relapsed; Stem cell transplantation
A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin
Keywords: ریفلاکس; Ovarian cancer; Chemotherapy; Gemcitabine; Pegylated liposomal doxorubicin; Relapsed; Phase II; Salvage
Optimal Use of Bendamustine in Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphomas, and Multiple Myeloma: Treatment Recommendations From an International Consensus Panel
Keywords: ریفلاکس; Alkylating agent; Non-Hodgkin's lymphoma; Phase I trial; Refractory; Relapsed; Rituximab
The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma
Keywords: ریفلاکس; Mesothelioma; Relapsed; Vinorelbine; Second-line
The efficacy of arsenic trioxide for the treatment of relapsed and refractory multiple myeloma: A systematic review
Keywords: ریفلاکس; Multiple myeloma; Plasmacytoma; Relapsed; Refractory; Arsenic; ATO; Efficacy; Systematic review
Allogeneic Stem Cell Transplantation for Patients with Relapsed Chemorefractory Aggressive Non-Hodgkin Lymphomas
Keywords: ریفلاکس; Aggressive non-Hodgkin lymphoma; Allogeneic stem cell transplantation; Refractory; Relapsed; Graft-versus-host disease
Phase II Study of Celecoxib and Docetaxel in Non-small Cell Lung Cancer (NSCLC) Patients with Progression after Platinum-Based Therapy
Keywords: ریفلاکس; Non-small cell lung cancer; COX-2; Relapsed; Docetaxel; Celecoxib
Salvage Therapy for Relapsed/Refractory Diffuse Large B Cell Lymphoma
Keywords: ریفلاکس; Diffuse large B cell lymphoma; Relapsed; Refractory; Salvage therapy
Chemotherapy for Relapsed Small Cell Lung Cancer: A Systematic Review and Practice Guideline
Keywords: ریفلاکس; Small cell lung cancer; Chemotherapy; Relapsed; Re-treatment; Systematic review
Treatment of Relapsed Idiopathic Clubfoot by Complete Subtalar Release Combined With the Ilizarov Method
Keywords: ریفلاکس; relapsed; recurrent; clubfoot; Ilizarov; subtalar release
Modified Magrath IVAC regimen as second-line therapy for relapsed or refractory aggressive non-Hodgkin's lymphoma in developing countries: The experience of a single center in Brazil
Keywords: ریفلاکس; Second-line therapy; Relapsed; Refractory; Aggressive non-Hodgkin's lymphoma
DHEAS and POMS measures identify cocaine dependence treatment outcome
Keywords: ریفلاکس; Cocaine; Profile of mood states; Dehydroepiandrosterone sulphate; DHEA; DHEAS; Dehydroepiandrosterone; Cortisol; Abstinent; Relapsed; Dropped out;